THE UNITED STATES PHARMACOPEIAL CONVENTION

Registrant on federal lobbying filings · filed 2025 to 2026

$0 Income reported

1 Clients represented

6 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. It also reported $610,000 of in-house lobbying expenses, which is what a registrant files when it lobbies for itself. 1 filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the registrant's LDA id (400358632), not by name.

Clients 1

THE UNITED STATES PHARMACOPEIAL CONVENTION $610,000 6 filings

Lobbyists named 1

TIMOTHY J CASEY 1 filing · through 2025 Legislative Assistant, Rep. John Tierney; Legislative Correspondent, Sen. Tom Carper.

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $250,000 2 filings
2025 $360,000 4 filings

Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 4

HOUSE OF REPRESENTATIVES 6
SENATE 6
Centers For Medicare and Medicaid Services (CMS) 1
White House Office 1

Recent filings 7 total

1A

THE UNITED STATES PHARMACOPEIAL CONVENTION

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $130,000 expenses · posted Jul 20, 2026

View → Q2

THE UNITED STATES PHARMACOPEIAL CONVENTION

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $120,000 expenses · posted Jul 20, 2026

View → Q1

THE UNITED STATES PHARMACOPEIAL CONVENTION Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $110,000 expenses · posted Apr 20, 2026

View → Q4

THE UNITED STATES PHARMACOPEIAL CONVENTION

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $100,000 expenses · posted Jan 20, 2026

View → Q3

THE UNITED STATES PHARMACOPEIAL CONVENTION

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $80,000 expenses · posted Oct 20, 2025

View → Q2

THE UNITED STATES PHARMACOPEIAL CONVENTION

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $110,000 expenses · posted Jul 21, 2025

View → Q1

THE UNITED STATES PHARMACOPEIAL CONVENTION

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $70,000 expenses · posted Apr 21, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.